These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 26572664)

  • 21. Recent advances in the physiopathology of IgA nephropathy.
    Monteiro RC
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S1-S8. PubMed ID: 29606255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
    Lechner SM; Abbad L; Boedec E; Papista C; Le Stang MB; Moal C; Maillard J; Jamin A; Bex-Coudrat J; Wang Y; Li A; Martini PG; Monteiro RC; Berthelot L
    J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Sadaka C; Leroy V; Benhamou M; Novak J; Vrtovsnik F; Haddad E; Chintalacharuvu KR; Monteiro RC
    J Am Soc Nephrol; 2004 Mar; 15(3):622-34. PubMed ID: 14978164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89.
    van Zandbergen G; van Kooten C; Mohamad NK; Reterink TJ; de Fijter JW; van de Winkel JG; Daha MR
    Nephrol Dial Transplant; 1998 Dec; 13(12):3058-64. PubMed ID: 9870466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy.
    Moura IC; Centelles MN; Arcos-Fajardo M; Malheiros DM; Collawn JF; Cooper MD; Monteiro RC
    J Exp Med; 2001 Aug; 194(4):417-25. PubMed ID: 11514599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Gut-Renal Connection in IgA Nephropathy.
    Coppo R
    Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A
    Nefrologia; 2010; 30(5):501-7. PubMed ID: 20882091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the pathogenesis of IgA nephropathy.
    Floege J; Moura IC; Daha MR
    Semin Immunopathol; 2014 Jul; 36(4):431-42. PubMed ID: 24442210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
    Tamouza H; Chemouny JM; Raskova Kafkova L; Berthelot L; Flamant M; Demion M; Mesnard L; Paubelle E; Walker F; Julian BA; Tissandié E; Tiwari MK; Camara NO; Vrtovsnik F; Benhamou M; Novak J; Monteiro RC; Moura IC
    Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
    Novak J; Vu HL; Novak L; Julian BA; Mestecky J; Tomana M
    Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.
    Wehbi B; Oblet C; Boyer F; Huard A; Druilhe A; Paraf F; Cogné E; Moreau J; El Makhour Y; Badran B; Van Egmond M; Cogné M; Aldigier JC
    J Am Soc Nephrol; 2019 Jul; 30(7):1238-1249. PubMed ID: 31227634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gluten and IgA nephropathy: you are what you eat?
    Cheung CK; Barratt J
    Kidney Int; 2015 Aug; 88(2):215-8. PubMed ID: 26230197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deposition of IgA in primary IgA nephropathy: it takes at least four to tango.
    Daha MR; van Kooten C
    Nephrol Dial Transplant; 2013 Apr; 28(4):794-7. PubMed ID: 23234754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition.
    van der Boog PJ; van Kooten C; van Zandbergen G; Klar-Mohamad N; Oortwijn B; Bos NA; van Remoortere A; Hokke CH; de Fijter JW; Daha MR
    Nephrol Dial Transplant; 2004 Nov; 19(11):2729-36. PubMed ID: 15340093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
    Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
    van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
    Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.